Furthermore, this study provided evidence for the first time that LINC01133 exerted oncogenic functions in human NSCLC cells by interacting with EZH2 and LSD1, and repressing KLF2, P21 and E-cadherin expression. The gene discussed is CDH1; the disease is non-small cell lung carcinoma.